References
-
1) Non-Esterified Fatty Acid-Induced Apoptosis in Bovine Granulosa Cells via ROS-Activated PI3K/AKT/FoxO1 Pathway.
Product: PGAM1 Antibody (#DF12693)Year: 2023Journal: Antioxidants (Basel)ImpactFactor: 7DOI: 10.3390/antiox12020434PMID: 36829992 -
2) Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
Product: PGAM1 Antibody (#DF12693)Year: 2022Journal: BIOMED PHARMACOTHERImpactFactor: 7.5DOI: 10.1016/j.biopha.2022.113063PMID: 35658233 -
3) Proteomic analyses reveal higher levels of neutrophil activation in men than in women with systemic lupus erythematosus.
Product: PGAM1 Antibody (#DF12693)Year: 2022Journal: FRONT IMMUNOLImpactFactor: 7.3DOI: 10.3389/fimmu.2022.911997PMID: 35799787 -
4) Effect of β-chitosan on the binding interaction between SARS-CoV-2 S-RBD and ACE2.
-
5) P38α deficiency in macrophages ameliorates murine experimental colitis by regulating inflammation and immune process.
Product: OAS2 Antibody (#DF12680)Year: 2022Journal: PATHOL RES PRACTImpactFactor: 2.8DOI: 10.1016/j.prp.2022.153881PMID: 35430508 -
6) Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
Product: NKCC2 Antibody (#DF12671)Year: 2021Journal: HYPERTENS RESImpactFactor: 5.4DOI: 10.1038/s41440-020-00548-3PMID: 32908237 -
7) PA-MSHA Regulates PD-L1 Expression in Hepatoma Cells.
Product: MGAT1 Antibody (#DF12658)Year: 2023Journal: IMMUNOL INVESTImpactFactor: 2.8DOI: 10.1080/08820139.2023.2177168PMID: 36762677 -
8) Acupoint application inhibits nerve growth factor and attenuates allergic inflammation in allergic rhinitis model rats.
Product: MCC Antibody (#DF12654)Year: 2020Journal: J INFLAMM-LONDImpactFactor: 5.1DOI: 10.1186/s12950-020-0236-9PMID: 32063751 -
9) Elevated latent transforming growth factor beta binding protein 2 in endometriosis promotes endometrial stromal cell invasion and proliferation via the NF-kB signaling pathway.
Product: LTBP2 Antibody (#DF12653)Year: 2022Journal: MOL CELL ENDOCRINOLImpactFactor: 4.1DOI: 10.1016/j.mce.2022.111647PMID: 35429597 -
10) Identification of potential pathogenic super-enhancers-driven genes in pulmonary fibrosis.
Product: LTBP2 Antibody (#DF12653)Year: 2021Journal: FRONT GENETImpactFactor: 3.7DOI: 10.3389/fgene.2021.644143PMID: 34054916 -
11) LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells.
Product: LAP3 Antibody (#DF12651)Year: 2022Journal: BMC CANCERImpactFactor: 3.8DOI: 10.1186/s12885-022-09963-wPMID: 35941558 -
12) IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription.
Product: IRF1 Antibody (#DF12645)Year: 2021Journal: AGING-USImpactFactor: 5.2DOI: 10.18632/aging.202204PMID: 33424012 -
13) Transcriptomics and metabolomics reveal the role of CYP1A2 in psoralen/isopsoralen-induced metabolic activation and hepatotoxicity.
Product: GSTA2 Antibody (#DF12623)Year: 2023Journal: Phytother ResImpactFactor: 7.2DOI: 10.1002/ptr.7604PMID: 36056681 -
14) Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.
Product: G6PC Antibody (#DF12610)Year: 2023Journal: PhytomedicineImpactFactor: 7.9DOI: 10.1016/j.phymed.2022.154634PMID: 36603341 -
15) Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Product: Cytohesin2 Antibody (#DF12592)Year: 2020Journal: J CANCER RES CLINImpactFactor: 3.6DOI: 10.1007/s00432-019-03090-zPMID: 31758243